European Heart Journal Advance Access originally published online on January 30, 2009
European Heart Journal 2009 30(4):391-393; doi:10.1093/eurheartj/ehp024
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org
Treatment of heart failure in the elderly: never say it's too late
1 Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, 25100 Brescia, Italy
2 University of California, San Francisco and the San Francisco VA Medical Center, San Francisco, CA, USA
* Corresponding author. Tel: +39 030 3995573, Fax: +39 030 3700359, Email: metramarco@libero.it
This editorial refers to Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
, by M. Komajda on page 478
Footnotes
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
| The first 150 words of the full text of this article appear below. |
Komajda et al. have provided very important information on an essential and relatively unstudied group of heart failure (HF) patients—those 80 years of age and older.1 Their findings from the Euro Heart Failure Survey (EHFS) II provide unique information on the characteristics and outcomes in this group and secular trends in their management. In this editorial, we will try to place their findings in the broader context of HF management, highlighting what is known and, more importantly, what is not known about this patient group.
The background: heart failure as a disease of the elderly
HF is predominantly a disease of the elderly. The mean age of HF patients is >70 years in most developed countries, and the prevalence of HF rises dramatically with age, from 1–2% among individuals aged 45–54 years to >10% among
Which are the desired effects? What is the evidence for treatment in the elderly?
Where are we now? What remains to be done?
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
- Michel Komajda, Olivier Hanon, Matthias Hochadel, Jose Luis Lopez-Sendon, Ferenc Follath, Piotr Ponikowski, Veli-Pekka Harjola, Helmut Drexler, Kenneth Dickstein, Luigi Tavazzi, and Markku Nieminen
EHJ 2009 30: 478-486.[Abstract] [Full Text]